OrthoPediatrics (KIDS) Stock Forecast & Price Target

Compare

117 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

KIDS Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

OrthoPediatrics

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

KIDS Stock 12 Month Forecast

Average Price Target

$24.00

▲(36.36% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for OrthoPediatrics in the last 3 months. The average price target is $24.00 with a high forecast of $34.00 and a low forecast of $18.00. The average price target represents a 36.36% change from the last price of $17.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","20":"$20","25":"$25","30":"$30","35":"$35"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$34.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,20,25,30,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.94,19.175384615384615,20.410769230769233,21.646153846153847,22.88153846153846,24.11692307692308,25.352307692307694,26.587692307692308,27.823076923076925,29.05846153846154,30.293846153846154,31.52923076923077,32.76461538461538,{"y":34,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.94,18.40615384615385,18.872307692307693,19.33846153846154,19.804615384615385,20.270769230769233,20.736923076923077,21.203076923076924,21.66923076923077,22.135384615384616,22.60153846153846,23.067692307692308,23.533846153846156,{"y":24,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.94,17.944615384615386,17.94923076923077,17.953846153846154,17.95846153846154,17.963076923076922,17.967692307692307,17.972307692307695,17.97692307692308,17.981538461538463,17.986153846153847,17.99076923076923,17.995384615384616,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.36,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.93,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.18,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.22,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.05,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.93,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.86,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.39,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$34.00

Average Price Target$24.00

Lowest Price Target$18.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Canaccord Genuity

Not Ranked

Canaccord Genuity

$24

Buy

36.36%

Upside

Initiated

12/10/25

OrthoPediatrics initiated with a Buy at CanaccordOrthoPediatrics initiated with a Buy at Canaccord

Rick Wise

Stifel Nicolaus

$20

Buy

13.64%

Upside

Reiterated

10/29/25

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Michael Matson

Needham

$42→$26

Buy

47.73%

Upside

Assigned

10/29/25

OrthoPediatrics: Buy Rating Affirmed Amidst Growth Potential and Operational Efficiency

Ryan Zimmerman

BTIG

$23

Buy

30.68%

Upside

Reiterated

10/29/25

OrthoPediatrics (KIDS) Gets a Buy from BTIG

Matthew O'Brien

Piper Sandler

$22

Buy

25.00%

Upside

Reiterated

10/29/25

Piper Sandler Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Richard Newitter

Truist Financial

$22→$18

Hold

2.27%

Upside

Reiterated

10/10/25

OrthoPediatrics (KIDS) Receives a Hold from Truist FinancialLowering Ests & PT to $18 (from $22)

David Turkaly

Citizens JMP

$35→$25

Buy

42.05%

Upside

Reiterated

10/10/25

OrthoPediatrics price target lowered to $25 from $35 at Citizens JMPOrthoPediatrics price target lowered to $25 from $35 at Citizens JMP

Ben Haynor

Lake Street

$34

Buy

93.18%

Upside

Reiterated

10/10/25

Lake Street Remains a Buy on OrthoPediatrics (KIDS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Canaccord Genuity

Not Ranked

Canaccord Genuity

$24

Buy

36.36%

Upside

Initiated

12/10/25

OrthoPediatrics initiated with a Buy at CanaccordOrthoPediatrics initiated with a Buy at Canaccord

Rick Wise

Stifel Nicolaus

$20

Buy

13.64%

Upside

Reiterated

10/29/25

Stifel Nicolaus Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Michael Matson

Needham

$42→$26

Buy

47.73%

Upside

Assigned

10/29/25

OrthoPediatrics: Buy Rating Affirmed Amidst Growth Potential and Operational Efficiency

Ryan Zimmerman

BTIG

$23

Buy

30.68%

Upside

Reiterated

10/29/25

OrthoPediatrics (KIDS) Gets a Buy from BTIG

Matthew O'Brien

Piper Sandler

$22

Buy

25.00%

Upside

Reiterated

10/29/25

Piper Sandler Sticks to Its Buy Rating for OrthoPediatrics (KIDS)

Richard Newitter

Truist Financial

$22→$18

Hold

2.27%

Upside

Reiterated

10/10/25

OrthoPediatrics (KIDS) Receives a Hold from Truist FinancialLowering Ests & PT to $18 (from $22)

David Turkaly

Citizens JMP

$35→$25

Buy

42.05%

Upside

Reiterated

10/10/25

OrthoPediatrics price target lowered to $25 from $35 at Citizens JMPOrthoPediatrics price target lowered to $25 from $35 at Citizens JMP

Ben Haynor

Lake Street

$34

Buy

93.18%

Upside

Reiterated

10/10/25

Lake Street Remains a Buy on OrthoPediatrics (KIDS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OrthoPediatrics

1 Month

xxx

Success Rate

16/28 ratings generated profit

Average Return

+0.88%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +0.88% per trade.

3 Months

xxx

Success Rate

11/24 ratings generated profit

Average Return

-2.53%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of -2.53% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

8/24 ratings generated profit

Average Return

-10.51%

reiterated a buy rating 2 months ago

Copying Rick Wise's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -10.51% per trade.

2 Years

xxx

Success Rate

4/24 ratings generated profit

Average Return

-19.82%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -19.82% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KIDS Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, KIDS has received 11 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. KIDS average Analyst price target in the past 3 months is 24.00.

Each month's total comprises the sum of three months' worth of ratings.

KIDS Financial Forecast

KIDS Earnings Forecast

Next quarter’s earnings estimate for KIDS is -$0.30 with a range of -$0.40 to -$0.21. The previous quarter’s EPS was -$0.24. KIDS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year KIDS has Performed in-line its overall industry.

KIDS Sales Forecast

Next quarter’s sales forecast for KIDS is $59.28M with a range of $58.80M to $59.68M. The previous quarter’s sales results were $61.25M. KIDS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year KIDS has Performed in-line its overall industry.

KIDS Stock Forecast FAQ

What is KIDS’s average 12-month price target, according to analysts?

Based on analyst ratings, Orthopediatrics Corp’s 12-month average price target is 24.00.

What is KIDS’s upside potential, based on the analysts’ average price target?

Orthopediatrics Corp has 36.36% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is KIDS a Buy, Sell or Hold?

Orthopediatrics Corp has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Orthopediatrics Corp’s price target?

The average price target for Orthopediatrics Corp is 24.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $34.00 ,the lowest forecast is $18.00. The average price target represents 36.36% Increase from the current price of $17.6.

What do analysts say about Orthopediatrics Corp?

Orthopediatrics Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of KIDS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

OrthoPediatrics (KIDS) Stock Forecast & Price Target

KIDS Analyst Ratings

KIDS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering OrthoPediatrics

KIDS Analyst Recommendation Trends

KIDS Financial Forecast

KIDS Earnings Forecast

KIDS Sales Forecast

KIDS Stock Forecast FAQ

Detailed List of Analyst Forecasts